If you are in that majority, Ros Insurance Concierge cannot help you
Retatrutide is a new, powerful weight loss medication developed by Eli Lilly that simultaneously activates three key receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors
Others prefer morning shots to align with their meal-planning routine
Patients inject the medication into fatty tissue, typically in the abdomen, thigh, or upper arm
Research suggests GIP can enhance GLP-1's effects on insulin secretion through synergistic pancreatic effects, and may provide metabolic benefits including bone health preservation during weight loss and maintenance of energy expenditure
11 For these people, thats a lot of wasted time and expense (not to mention the discomfort of any side effects) for a drug that doesnt work